Literature DB >> 7053701

Functional hyposplenia after splenic irradiation for Hodgkin's disease.

C N Coleman, I R McDougall, M O Dailey, P Ager, S Bush, H S Kaplan.   

Abstract

We previously reported a patients who developed fulminant pneumococcal sepsis 12 years after successful treatment for Hodgkin's disease, which included splenic irradiation. We have since evaluated splenic size and function in 25 patients who had received splenic irradiation 5 to 16 years previously either for Hodgkin's disease (n = 19) or non-Hodgkin's lymphoma (n = 6). Mean maximum splenic diameter as measured on a 99mTc-sulfur colloid liver-spleen scan was 6.2 cm in the irradiated group and 9.7 cm in a control group (p less than 0.001). The mean percentage of erythrocytes containing pits when observed with interference phase microscopy was 13.0% in the irradiated group, which was significantly different (p less than 0.001) from the levels found in each of the control groups: normal subjects, 0.9%; unstaged and untreated lymphoma patients, 0.6%; and patients after splenectomy, 33.7%. Patients who have had splenic irradiation should be considered at risk of developing overwhelming pneumococcal sepsis.

Entities:  

Mesh:

Year:  1982        PMID: 7053701     DOI: 10.7326/0003-4819-96-1-44

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

1.  Pneumococcal Vaccine And Hodgkin's Disease.

Authors:  M L Brigden
Journal:  Can Fam Physician       Date:  1985-09       Impact factor: 3.275

2.  Late Infection-Related Mortality in Asplenic Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.

Authors:  Brent R Weil; Arin L Madenci; Qi Liu; Rebecca M Howell; Todd M Gibson; Yutaka Yasui; Joseph P Neglia; Wendy M Leisenring; Susan A Smith; Emily S Tonorezos; Danielle N Friedman; Louis S Constine; Christopher L Tinkle; Lisa R Diller; Gregory T Armstrong; Kevin C Oeffinger; Christopher B Weldon
Journal:  J Clin Oncol       Date:  2018-04-17       Impact factor: 44.544

3.  Partial splenectomy in children: an alternative for splenectomy in the pathological staging of Hodgkin's disease.

Authors:  H J Hoekstra; R Y Tamminga; W Timens
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

4.  Effect of splenectomy and the functional hyposplenism of coeliac disease on auto-antibody formation.

Authors:  J G O'Grady; F M Stevens; B Harding; J Flynn; M P Little; C F McCarthy
Journal:  Ir J Med Sci       Date:  1984-10       Impact factor: 1.568

5.  Treatment of early-stage Hodgkin's disease.

Authors:  M L Brigden
Journal:  CMAJ       Date:  1985-12-01       Impact factor: 8.262

Review 6.  Practical review of immunizations in adult patients with cancer.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Hum Vaccin Immunother       Date:  2015-06-25       Impact factor: 3.452

7.  Return of splenic function after splenectomy: how much tissue is needed?

Authors:  G R Corazza; C Tarozzi; D Vaira; M Frisoni; G Gasbarrini
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

Review 8.  Overwhelming postsplenectomy infection still a problem.

Authors:  M L Brigden
Journal:  West J Med       Date:  1992-10

9.  Aspects of splenic hypofunction in old age.

Authors:  M A Zago; M S Figueiredo; D T Covas; C Bottura
Journal:  Klin Wochenschr       Date:  1985-07-01

10.  Stereotactic Body Radiation Therapy to a Splenic Metastasis in Oligoprogressive Non-small Cell Lung Cancer.

Authors:  Daniel W Kim; Grace Lee; Hwan Lee; Jack M Qian; Nina N Sanford; Miranda B Lam; Naeem Tahir; Harvey J Mamon
Journal:  Adv Radiat Oncol       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.